Stock GLAXO GLAXOSMITHKLINE PHARMACEUTICALS LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Insiders GlaxoSmithKline Pharmaceuticals Limited

Equities

GLAXO

INE159A01016

Market Closed - Bombay S.E.
Other stock markets
 06:00:49 2024-04-29 am EDT 		5-day change 1st Jan Change
2,112 INR -0.98% Intraday chart for GlaxoSmithKline Pharmaceuticals Limited +13.01% +11.30%
Apr. 25 GlaxoSmithKline sues Pfizer and BioNTech over Covid-19 vaccine technology RE
Mar. 22 GlaxoSmithKline Pharmaceuticals Limited Receives Orders from Government Authorities CI

Insiders

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Cynata Therapeutics Names Chief Business Officer; Shares Plunge 14%
MT
Glaxosmithkline Pharmaceuticals Limited Appoints Aparajita Mukherjee Rajput, Technology Lead
CI
GlaxoSmithKline Pharmaceuticals Limited Announces Resignation of Sunder Ramachandran as Head of Commercial Excellence, Effective 12 January 2024
CI
GlaxoSmithKline Pharmaceuticals Limited Announces Resignation of Abhinav Kashyap as Pharma Technology Lead
CI
GlaxoSmithKline Pharmaceuticals Limited Appoints Omkar Parnandiwar as Head of Omnichannel, Effective November 1, 2023
CI
GlaxoSmithKline Pharmaceuticals Names New Managing Director
MT
GlaxoSmithKline Pharmaceuticals Limited Announces Executive Changes
CI
Glaxosmithkline Pharmaceuticals Limited Announces Resignation of Nihal Kaviratne as Board Member
CI
GlaxoSmithkline Pharmaceuticals Limited Announces Nihal Kaviratne Voluntarily Relinquished as Board Member, Effective July 26, 2022
CI
GlaxoSmithkline Pharmaceuticals Limited Announces Resignation of Mark Dawson as Non- Executive Director
CI
GlaxoSmithKline Pharmaceuticals Limited Announces Appointment of Manu Anand as Additional Independent Director
CI
GlaxoSmithKline Pharmaceuticals Limited Announces Appointment of Juby Chandy as Chief Financial Officer
CI
GlaxoSmithKline Pharmaceuticals Limited Announces Appointment of Juby Chandy as A Whole-Time Director
CI
GlaxoSmithKline Pharmaceuticals Limited Announces Executive Changes
CI
Glaxosmithkline Pharmaceuticals Limited Approves Directorate Changes
CI
GlaxoSmithKline Pharmaceuticals Limited Recommends Common and Special Dividend for the Year Ended March 31, 2020; Appoints Sunita Maheshwari as an Additional Independent Director
CI
GlaxoSmithKline Pharmaceuticals Limited Announces Managing Director Changes, Effective 1 April 2020
CI
GlaxoSmithkline Pharmaceuticals Limited Announces Board Changes
CI
GlaxoSmithkline Pharmaceuticals Limited Announces Change in Directorate
CI
GlaxoSmithkline Pharmaceuticals Limited Announces Cessation of Mr. Andrew Aristidou to Be A Director & CFO
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. GLAXO Stock
  4. News GlaxoSmithKline Pharmaceuticals Limited
  5. Insiders